Department of Ultrasound, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Med Sci Monit. 2020 Feb 19;26:e920546. doi: 10.12659/MSM.920546.
BACKGROUND Hypoparathyroidism is a common complication after thyroidectomy. Calcium supplementation can relieve these symptoms, but it is not clear whether it can protect the parathyroid glands. This study aimed to verify whether Ca²⁺ inhibits the apoptosis of parathyroid cells following ischemic injury. MATERIAL AND METHODS A rabbit model of parathyroid gland ischemic injury was established. The blood calcium concentrations were measured by colorimetry. The parathyroid hormone (PTH) levels were measured by enzyme-linked immunosorbent assay (ELISA). The parathyroid tissues were observed by hematoxylin and eosin (H&E) staining and the TdT-mediated dUTP nick-end labeling (TUNEL) assay. Western blotting was used to quantify the levels of the following proteins: caspase-3 and p38 MAP Kinase (p38 MAPK). RESULTS This study demonstrates that apoptosis can be a part of the pathological changes associated with parathyroid ischemic injury. Calcium supplementation inhibited the apoptosis of parathyroid cells following ischemic injury. There were no significant differences among the serum calcium levels from the Sham operation (Sham), the Control group (CG), or the Calcium supplementation group (CSG) after 24 h, 72 h, and 168 h of treatment. PTH levels in the CG were significantly higher than in the CSG at 24 h and 72 h after treatments. The apoptosis rate of parathyroid cells from rabbits in the CSG was significantly lower than that of those from rabbits in the CG at 24 h and 72 h after the treatment. Calcium supplementation inhibited p38 MAPK and caspase-3 expression. CONCLUSIONS This study demonstrates that calcium supplementation inhibited the apoptosis of parathyroid cells following ischemic injury.
甲状旁腺功能减退症是甲状腺切除术后的常见并发症。钙补充剂可以缓解这些症状,但尚不清楚它是否能保护甲状旁腺。本研究旨在验证 Ca²⁺是否能抑制缺血性损伤后甲状旁腺细胞的凋亡。
建立兔甲状旁腺缺血性损伤模型。通过比色法测量血钙浓度。通过酶联免疫吸附测定(ELISA)测量甲状旁腺激素(PTH)水平。通过苏木精和伊红(H&E)染色和末端转移酶介导的 dUTP 缺口末端标记(TUNEL)检测观察甲状旁腺组织。通过 Western blot 定量检测以下蛋白的水平:半胱天冬酶-3 和 p38 MAP 激酶(p38 MAPK)。
本研究表明,凋亡可能是与甲状旁腺缺血性损伤相关的病理变化的一部分。钙补充抑制了缺血性损伤后甲状旁腺细胞的凋亡。在治疗后 24 小时、72 小时和 168 小时,Sham 手术(Sham)、对照组(CG)和钙补充组(CSG)的血清钙水平之间没有显著差异。CG 中的 PTH 水平在治疗后 24 小时和 72 小时明显高于 CSG。治疗后 24 小时和 72 小时,CSG 中甲状旁腺细胞的凋亡率明显低于 CG。钙补充抑制了 p38 MAPK 和半胱天冬酶-3 的表达。
本研究表明,钙补充抑制了缺血性损伤后甲状旁腺细胞的凋亡。